Delivery Order HT942523D0014-HT942523F0370
Award Date
9/25/23
Potential Completion Date
10/31/23
Potential Value
$31K
Federal Agency
Defense Health Agency
Awardee
Elta 90 Medical Genetics LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Georgia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a firm-fixed-price purchase order contract to Elta 90 Medical Genetics LLC, a small business joint venture, for the WRAIR_MISEQ MAINTENANCE CONTRACT. The contract has a ceiling value of $120,059 and a period of performance through March 19, 2026. Elta 90 Medical Genetics LLC is a for-profit limited liability company that specializes in providing genetic sequencing equipment, supplies, and maintenance services to defense agencies. This contract is not set aside...
Elta 90 Medical Genetics LLC has been awarded a $122,000 firm fixed price purchase order by the Defense Advanced Research Projects Agency (DARPA) to provide WRAIR_ILLUMINA MISEQ services. The contract has a period of performance from August 17, 2023 through September 30, 2023, with work to be conducted in Gürcistan. DARPA's high-level programs involve advancing technologies with potential military applications, suggesting this contract supports research using next-generation DNA sequencing...
<p>The WRAIR_MISEQ_MAINTENANCE CONTRACT is a federal purchase order awarded by the Defense Advanced Research Projects Agency (DARPA) to Elta 90 Medical Genetics LLC, a for-profit limited liability company. The contract is for firm fixed-price maintenance services and has a potential value of $69,720.00. The contract does not have a set-aside designation and will be performed in Georgia. The contract has a completion date of February 14, 2025.</p>
This is a firm fixed price delivery order contract awarded by the Medical Command (MEDCOM) agency of the U.S. Department of Defense to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $90,965.84 and is for the provision of MiSeq Reagent Kit V3 products. The contract is not associated with any set-aside provisions. Through past prime federal contract awards, Illumina has provided sequencing systems, reagents, and...
The U.S. Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents, to provide MiSeq Reagent Kits for $129,820.35. This award, which has no set-aside designation, supports the agency's ongoing requirements for nucleic acid sequencing capabilities. Illumina has previously received prime federal contracts from agencies like the National Institutes of Health, Centers for...
The Defense Health Agency, a component of the Department of Defense, awarded a $672,403 firm fixed price blanket purchase agreement call contract to Verogen, Inc. for MISEQ reagent kits. Verogen will deliver the reagent kits to support next generation sequencing under the contract, which runs from July 2, 2021 through September 28, 2021 and was awarded without any set aside designation. As the DHA works to advance genomic medicine for military service members, families, and veterans, this...
This federal contract was awarded by the Defense Health Agency to Illumina, Inc., a for-profit organization and manufacturer of genomic sequencing instruments and reagents. The $375,174.60 firm fixed price contract is for the delivery of MiSeq Reagent Kits to support genetic analysis and sequencing work, with a performance period ending on October 1, 2018. No set-aside designation was used for this award. Illumina has previously received contracts and sub-contracts from various federal agencies,...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of Urinary Pathogen ID/AMR Enrichment Kits. The $61,848.39 contract has a period of performance through September 30, 2024 and will support the use of government-owned Illumina MiSeq sequencing instruments at Tripler Army Medical Center in Hawaii. The award was made on a sole source basis under the simplified acquisition...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of...
This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing and analysis solutions. The $456,023.48 contract provides various reagents and consumables, including TruSeq Cluster Kit V3, PhiX Control V3 Kit, and TruSeq Small RNA Library Prep Kit V2, to support genomic sequencing and analysis capabilities. Illumina has a history of providing sequencing systems, reagents, and services to federal agencies such...